| 000 | 02783 a2200757 4500 | ||
|---|---|---|---|
| 005 | 20250514165155.0 | ||
| 264 | 0 | _c20040126 | |
| 008 | 200401s 0 0 eng d | ||
| 022 | _a0022-3042 | ||
| 024 | 7 |
_a10.1046/j.1471-4159.2003.02096.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSarker, Krishna P | |
| 245 | 0 | 0 |
_aEbselen inhibits NO-induced apoptosis of differentiated PC12 cells via inhibition of ASK1-p38 MAPK-p53 and JNK signaling and activation of p44/42 MAPK and Bcl-2. _h[electronic resource] |
| 260 |
_bJournal of neurochemistry _cDec 2003 |
||
| 300 |
_a1345-53 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnnexin A5 _xmetabolism |
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 |
_aAzoles _xpharmacology |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 |
_aButadienes _xpharmacology |
| 650 | 0 | 4 | _aCaspase 3 |
| 650 | 0 | 4 |
_aCaspases _xmetabolism |
| 650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aChaperonin 60 _xmetabolism |
| 650 | 0 | 4 |
_aCyclooxygenase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aCytochromes c _xmetabolism |
| 650 | 0 | 4 |
_aDithiothreitol _xpharmacology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aIsoindoles |
| 650 | 0 | 4 | _aJNK Mitogen-Activated Protein Kinases |
| 650 | 0 | 4 | _aMAP Kinase Kinase Kinase 5 |
| 650 | 0 | 4 |
_aMAP Kinase Kinase Kinases _xmetabolism |
| 650 | 0 | 4 |
_aMitogen-Activated Protein Kinases _xmetabolism |
| 650 | 0 | 4 |
_aNerve Growth Factor _xpharmacology |
| 650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
| 650 | 0 | 4 |
_aNitric Oxide Donors _xpharmacology |
| 650 | 0 | 4 |
_aNitriles _xpharmacology |
| 650 | 0 | 4 |
_aNitroprusside _xpharmacology |
| 650 | 0 | 4 |
_aOrganoselenium Compounds _xpharmacology |
| 650 | 0 | 4 | _aPC12 Cells |
| 650 | 0 | 4 |
_aPropidium _xmetabolism |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aSerine _xmetabolism |
| 650 | 0 | 4 |
_aSodium Selenite _xpharmacology |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTransfection |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xmetabolism |
| 650 | 0 | 4 |
_aVitamin E _xpharmacology |
| 650 | 0 | 4 | _ap38 Mitogen-Activated Protein Kinases |
| 700 | 1 | _aBiswas, Kamal K | |
| 700 | 1 | _aRosales, Jesusa L | |
| 700 | 1 | _aYamaji, Kazuyo | |
| 700 | 1 | _aHashiguchi, Teruto | |
| 700 | 1 | _aLee, Ki-Young | |
| 700 | 1 | _aMaruyama, Ikuro | |
| 773 | 0 |
_tJournal of neurochemistry _gvol. 87 _gno. 6 _gp. 1345-53 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1471-4159.2003.02096.x _zAvailable from publisher's website |
| 999 |
_c14442046 _d14442046 |
||